Published: December 2023
According to a recently published report by Roots Analysis, the growing prevalence of rare and chronic disorders is driving the plasma fractionation market growth
The global plasma fractionation market is anticipated to grow at a CAGR of 10% from 2023-2035, reaching USD 12.7 billion by 2035.
Plasma fractionation is a process that is employed to purify and separate plasma into individual protein components. These fractionates are then purified, which can further be used as therapeutic medicines, known as plasma-derived therapies or plasma-derived medicinal products. This involves a sequence of processes, including precipitation / chromatography, purification, and virus-inactivation. Fractionation is a highly developed bioprocess that can be carried out from small scale to commercial scale production. Plasma fractionation methods usually involve alteration of physical and chemical properties of plasma, which leads to change in solubility, and ultimately, the precipitation of target proteins. In some cases, the precipitation of plasma proteins is carried out through cryoprecipitation, a controlled temperature change method. Additionally, the protein precipitation process is facilitated by the addition of a precipitation or a separation agent. Once the proteins have been precipitated, they can be isolated using mechanical or chemical separation methods. It is worth highlighting that more than 30 unique therapeutic plasma proteins have already been developed through plasma fractionation which helps to treat various indications.
Browse 105+ figures and 130+ market data tables spread across 185+ pages and detailed Table of Content on “Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/plasma-fractionation-market.html
Various factors contribute to the market growth of plasma fractionators. These factors include growing demand for immunoglobulins and the increasing burden of bleeding disorders. Owning to the increasing burden of bleeding disorders, there is an evident surge in the need for safe and effective blood components. Plasma fractionates are used being for the treatment of various immunological, hematological and neurological disorders. Owing to the growing burden of the aforementioned disorders, the demand for effective therapies is anticipated to increase and is likely to present a lucrative opportunity for the plasma fractionators.
One of the primary restraints associated with this industry include the development of recombinant alternatives. In several developed nations, the recombinant factors have made a strong footprint. These recombinant factors offer extended half-life and last longer in the body as compared to the conventional blood products. Moreover, the demand for these recombinant factors has increased in the developing nations such as Brazil, India and China. Owing to the afore-mentioned factors, the expansion of plasma fractionation market size is anticipated to face some limitations.
Despite the challenges, several growth factors continue to drive the plasma fractionation market forward. One notable factor is the strategies adopted by the government to increase the regional self-sufficiency. Over the years, governments of various regions have been focused on increasing the regional self-sufficiency for plasma fractionates. These approaches have been designed to increase the availability of plasma fractionates within the region and to increase domestic production. Given the effort of government bodies and growing usage of these products, the market size of the plasma fractionation market is anticipated to observe a significant growth.
The plasma fractionation market report also includes detailed profiles of key players (listed below) that have the capability to perform plasma fractionation:
You Can Download Free Sample PDF Copy of This Report At:
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.firstname.lastname@example.org or email@example.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES